SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about updates

21 Jul 2026 Evaluate
Granules India has informed that it enclosed the Monitoring Agency Report with this letter for the quarter ended June 30, 2026, issued by India Ratings & Research, Monitoring Agency, in respect of the utilization of proceeds raised by the Company through Preferential Issue.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

854.45 -21.00 (-2.40%)
22-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.95
Dr. Reddys Labs. 1183.00
Cipla 1415.10
Lupin 2405.80
Zydus Lifesciences 1129.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: